StockUS listing USBSXNYSEHealthcareQuality Compounder

Boston Scientific Corp(BSX) Stock Analysis | Healthcare

USD --+0.00%
Reward67High
Risk25Low
75%Data
Strong 17% profit margin
USD —+0.00 (+0.00%) Previous close · NYSE
Market cap 60.85Bn
Reward Ratingⓘ67 High reward assessment · 75% data coverage
Top 25% of stocksView factors
Risk Ratingⓘ25 Low risk assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on BSX to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Boston Scientific Corp?

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.

AI Brief Pro

The brief on Boston Scientific Corp

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is Boston Scientific Corp?

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 60.85B, and a P/E ratio of 18.2x.

Financial Highlights

Investment Breakdown

Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
Profitability
Strong margins and consistent earnings support financial stability.
Risk
Below-average volatility supports a steadier risk profile.
Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: High (67)

Similar stocks to compare

A short list of Medical Devices names that are close enough in size to make side-by-side comparison useful.

Company Information
SectorHealthcare
IndustryMedical Devices
P/E Ratio18.1732
Beta0.585
Insider Activity
12M windowMixed
Shares soldShares bought
0-3months
0
12,040 shares
$100k
3-6months
0
5194,522 shares
$9.4M
6-9months
0
49,800 shares
$554k
9-12months
3178,214 shares
$16.8M
0

Openbook research

Articles mentioning BSX

3